Overview

The Effects of Peri-operative Pregabalin Administration on Post-operative Analgesia in Patients Undergoing Coronary Bypass Grafting

Status:
Unknown status
Trial end date:
2011-06-01
Target enrollment:
0
Participant gender:
All
Summary
We hypothesize that the perioperative administration of pregabalin will significantly decrease pain scores and post-operative opioid requirements for patients undergoing coronary artery bypass grafting, and reduces the incidence of opioid-induced side effects such as respiratory depression. This may reduce ICU admission and possibly abbreviate length of hospital stay.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University of Manitoba
Treatments:
Pregabalin
Criteria
Inclusion Criteria

- Patients whom are able and willing to provide written informed consent.

- Male and female 18-70 years of age.

- Patients whom are undergoing isolated coronary artery bypass grafting through a
midline sternotomy for the treatment of ischemic heart disease.

Exclusion criteria

- Patients undergoing cardiac surgery for valvular or pericardial surgery.

- Patients with a documented ejection fraction of less than 50%.

- Patients with known chronic renal insufficiency and a calculated creatinine clearance
of < 60mL/min.

- Patients with known sensitivity to the study drugs.

- Patients with documented pre-existing chronic pain.

- Patients with seizure disorders.

- Patients whom are taking pregabalin or gabapentin

- Patients on chronic neuroleptic medications for control of psychiatric disorders as to
avoid possible drug interactions and to avoid modulation of any pain states by such
medications.

- Patients whom are taking tricyclic antidepressants or serotonin and norepinephrine
re-uptake inhibitors(SNRI) will be excluded because of the effect of these drugs on
neuropathic pain.

- Patients greater than 70 years of age will also be excluded because of their increased
risk of side-effects and perioperative confusion.

- Pregnant or breast feeding females